Apidemia IVS: Financial statements 2018
CVR: 37503312
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Apidemia IVS (CVR 37503312) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 211,284 and a net result of DKK -355,318 compared with DKK -383,675 the year before. That is a decrease of 12.9% compared with the year before. Equity in the 2018 report amounted to DKK -1,000,925. The company had 2 employees in the financial year.
- Gross Profit
- DKK 211,284
- Profit/Loss
- DKK -355,318
- Equity
- DKK -1,000,925
- Total Assets
- DKK 101,067
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 211 t. | -355 t. | -1 mio. | 2 |
| 2017 | - | 243 t. | -384 t. | -646 t. | 2 |
| 2016 | - | -105 t. | -262 t. | -262 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Apidemia IVS has published its annual report for 2017. Gross profit came to DKK 242,557, and the net result was DKK -383,675.
About Apidemia IVS
Apidemia IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 10 November 2022. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company was previously named dotboost IVS. The company has 2 employees (2021). In 2020, the company reported a gross profit of DKK 161,017 and a net result of DKK -201,443 compared with DKK 59,896 the year before. Equity in the 2020 report amounted to DKK -1,142,472.